Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Avelos Therapeutics logo

Avelos Therapeutics

Recent Finacing

Series B

Recent Raise

$12.5M

Avelos Therapeutics is a Seoul-based biotech developing biomarker-driven small-molecule oncology therapeutics across preclinical and clinical stages, targeting undruggable targets via synthetic lethality, DNA damage response, and cell-cycle pathways.

Founded 2021
Seoul-t'ukpyolsi, South Korea
11-50
Private
avelostx.com

Highlights

Focus Areas

Biotechnology
Life Science
Precision Medicine

Recent Investors

QUAD Investment Management logo
SV Investment logo
Timefolio Asset Management logo
U
Mirae Asset Venture Investment logo
Mirae Asset Capital logo

Financials

$20.5M

Total Raised

2

Funding rounds

6

Investors